Results 131 to 140 of about 15,823 (164)

Impact of PSMA-Based Radiopharmaceuticals on the Clinical Management of Prostate Cancer. [PDF]

Cancers (Basel)
Guida C, Evangelista L, Spadafora M, Facchini G, Mansi L.   +4 more
europepmc   +1 more source

Bispecific Dual-Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients. [PDF]

J Cutan Pathol
Sina N, Muhaj F, Lenskaya V, Ivan D, Prieto VG, Curry JL.   +5 more
europepmc   +1 more source

Efficacy and toxicity of low-doses versus standard-dose enzalutamide in advanced prostate cancer: a real-world study with implications for cancer prevention/interception. [PDF]

BMC Cancer
Oliva M, Boitano M, Carbone A, Briata IM, Webber TB, Corradengo D, Introini C, Puntoni M, Ennas M, Germinale F, Provinciali N, Clavarezza M, Gozza A, Defferrari C, D'Amico M, Parnes HL, DeCensi A.   +16 more
europepmc   +1 more source

The Role of Nuclear Medicine in Prostate Cancer. [PDF]

Diagnostics (Basel)
Grozdic Milojevic I, Milojevic B, Skrijelj D, Bumbasirevic U, Janicic A, Kajmakovic B, Sobic-Saranovic D, Artiko V, Beatovic S.   +8 more
europepmc   +1 more source

Mechanisms of Progression and Challenges for Intervention in the Natural History of Early Prostate Cancer: A Narrative Review. [PDF]

Curr Oncol
Sandhu K, Pacey S, Brewer DS, Gnanapragasam VJ.   +3 more
europepmc   +1 more source

Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With Enzalutamide. [PDF]

Int J Urol
Kanaki T, Hatano K, Oka T, Tani M, Konishi M, Liu Y, Horitani H, Matsukawa A, Inoguchi S, Yoshimura A, Horibe Y, Sassi N, Okuda Y, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Kawashima A, Nonomura N.   +18 more
europepmc   +1 more source

Treatment-related changes in the prostate: past, present and future therapies. [PDF]

Histopathology
Collins K, Cheng L.
europepmc   +1 more source

Risk Factors and Clinical Significance of Grade ≥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer. [PDF]

In Vivo
Sato R, Yoshimi Y, Nishio T, Matsunaga YU, Matsumoto R.   +4 more
europepmc   +1 more source

[¹⁸F] PSMA PET-CT and [¹⁸F] Choline PET-CT in the Diagnosis of High-Risk Localized Prostate Cancer: Comparation of Both Tests. [PDF]

Prostate
Tárraga-Honrubia MA, Salinas-Sánchez AS, Navarro-Jiménez S, Lorenzo-Sánchez MV, Carrión-López P, Giménez-Bachs JM.   +5 more
europepmc   +1 more source

Assessment of cytotoxic effects of Prunus Africana extracts on prostate cancer C4-2 cells in vitro. [PDF]

BMC Complement Med Ther
Asuzu PC, Croston V, Rivera Y, Aryee ANA, Besong SA, Miletti-González KE.   +5 more
europepmc   +1 more source